| Product Code: ETC6748486 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Neurodegenerative Disease Treatment Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Neurodegenerative Disease Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 China Neurodegenerative Disease Treatment Market - Industry Life Cycle |
3.4 China Neurodegenerative Disease Treatment Market - Porter's Five Forces |
3.5 China Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 China Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Drug Type:, 2021 & 2031F |
3.7 China Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Route of Administration:, 2021 & 2031F |
3.8 China Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Distribution Channel:, 2021 & 2031F |
4 China Neurodegenerative Disease Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurodegenerative diseases in China |
4.2.2 Technological advancements in healthcare leading to improved treatment options |
4.2.3 Growing awareness about neurodegenerative diseases and available treatment options |
4.3 Market Restraints |
4.3.1 High treatment costs and limited insurance coverage for neurodegenerative diseases |
4.3.2 Regulatory challenges and approval processes for new treatments |
4.3.3 Lack of skilled healthcare professionals specializing in neurodegenerative disease treatment |
5 China Neurodegenerative Disease Treatment Market Trends |
6 China Neurodegenerative Disease Treatment Market, By Types |
6.1 China Neurodegenerative Disease Treatment Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 China Neurodegenerative Disease Treatment Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 China Neurodegenerative Disease Treatment Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.1.4 China Neurodegenerative Disease Treatment Market Revenues & Volume, By Parkinsons Disease, 2021- 2031F |
6.1.5 China Neurodegenerative Disease Treatment Market Revenues & Volume, By Alzheimers Disease, 2021- 2031F |
6.1.6 China Neurodegenerative Disease Treatment Market Revenues & Volume, By Spinal Muscular Atrophy (SMA), 2021- 2031F |
6.1.7 China Neurodegenerative Disease Treatment Market Revenues & Volume, By Huntingtons Disease, 2021- 2031F |
6.1.8 China Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Neurodegenerative Disease Treatment Market, By Drug Type: |
6.2.1 Overview and Analysis |
6.2.2 China Neurodegenerative Disease Treatment Market Revenues & Volume, By N-methyl-D-aspartate Receptor Antagonists, 2021- 2031F |
6.2.3 China Neurodegenerative Disease Treatment Market Revenues & Volume, By Selective Serotonin Reuptake Inhibitors, 2021- 2031F |
6.2.4 China Neurodegenerative Disease Treatment Market Revenues & Volume, By Dopamine Inhibitors, 2021- 2031F |
6.2.5 China Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Neurodegenerative Disease Treatment Market, By Route of Administration: |
6.3.1 Overview and Analysis |
6.3.2 China Neurodegenerative Disease Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 China Neurodegenerative Disease Treatment Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3.4 China Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Neurodegenerative Disease Treatment Market, By Distribution Channel: |
6.4.1 Overview and Analysis |
6.4.2 China Neurodegenerative Disease Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 China Neurodegenerative Disease Treatment Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 China Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 China Neurodegenerative Disease Treatment Market Import-Export Trade Statistics |
7.1 China Neurodegenerative Disease Treatment Market Export to Major Countries |
7.2 China Neurodegenerative Disease Treatment Market Imports from Major Countries |
8 China Neurodegenerative Disease Treatment Market Key Performance Indicators |
8.1 Number of clinical trials for neurodegenerative disease treatments in China |
8.2 Adoption rate of innovative treatment technologies in neurodegenerative disease management |
8.3 Patient satisfaction and outcomes improvement measures in neurodegenerative disease treatment |
9 China Neurodegenerative Disease Treatment Market - Opportunity Assessment |
9.1 China Neurodegenerative Disease Treatment Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 China Neurodegenerative Disease Treatment Market Opportunity Assessment, By Drug Type:, 2021 & 2031F |
9.3 China Neurodegenerative Disease Treatment Market Opportunity Assessment, By Route of Administration:, 2021 & 2031F |
9.4 China Neurodegenerative Disease Treatment Market Opportunity Assessment, By Distribution Channel:, 2021 & 2031F |
10 China Neurodegenerative Disease Treatment Market - Competitive Landscape |
10.1 China Neurodegenerative Disease Treatment Market Revenue Share, By Companies, 2024 |
10.2 China Neurodegenerative Disease Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here